MedTrace Logo

Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer

NCT01487226 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2011-12-07

No results posted yet for this study

Summary

Purpose Primary endpoint

* To evaluate the 3-year disease free survival Second endpoints
* To evaluate the 3-year \& 5-year overall survival To analyze the toxicity and the quality of life

Conditions

Interventions

DRUG

paclitaxel

Paclitaxel 175 mg/m2 over 3 hr Repeat every 3 weeks \* 6 cycles

DRUG

Cisplatin 50mg/m2

Cisplatin 50mg/m2 Repeat every 3 weeks \* 6 cycles

Sponsors & Collaborators

  • Korean Gynecologic Oncology Group

    lead OTHER

Principal Investigators

  • Jong Min Lee, MD · Kyung-Hee University East-West Med. Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01487226 on ClinicalTrials.gov